This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhou, J.
Right arrow Articles by Saiman, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, J.
Right arrow Articles by Saiman, L.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, April 2006, p. 1547-1549, Vol. 44, No. 4
0095-1137/06/$08.00+0     doi:10.1128/JCM.44.4.1547-1549.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Compliance of Clinical Microbiology Laboratories in the United States with Current Recommendations for Processing Respiratory Tract Specimens from Patients with Cystic Fibrosis

Juyan Zhou,1 Elizabeth Garber,1 Manisha Desai,2 and Lisa Saiman1*

Department of Pediatrics, Columbia University, New York, New York,1 Department of Biostatistics, Columbia University, New York, New York2

Received 17 January 2006/ Accepted 25 January 2006

Respiratory tract specimens from patients with cystic fibrosis (CF) require unique processing by clinical microbiology laboratories to ensure detection of all potential pathogens. The present study sought to determine the compliance of microbiology laboratories in the United States with recently published recommendations for CF respiratory specimens. Microbiology laboratory protocols from 150 of 190 (79%) CF care sites were reviewed. Most described the use of selective media for Burkholderia cepacia complex (99%), Staphylococcus aureus (82%), and Haemophilus influenzae (89%) and identified the species of all gram-negative bacilli (87%). Only 52% delineated the use of agar diffusion assays for susceptibility testing of Pseudomonas aeruginosa. Standardizing laboratory practices will improve treatment, infection control, and our understanding of the changing epidemiology of CF microbiology.


* Corresponding author. Mailing address: Division of Infectious Diseases, Department of Pediatrics, Columbia University, College of Physicians & Surgeons, 650 West 168th St., PH 4 West Room 470, New York, NY 10032. Phone: (212) 305-9446. Fax: (212) 305-9491. E-mail: LS5{at}columbia.edu.


Journal of Clinical Microbiology, April 2006, p. 1547-1549, Vol. 44, No. 4
0095-1137/06/$08.00+0     doi:10.1128/JCM.44.4.1547-1549.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Dasenbrook, E. C., Merlo, C. A., Diener-West, M., Lechtzin, N., Boyle, M. P. (2008). Persistent Methicillin-resistant Staphylococcus aureus and Rate of FEV1 Decline in Cystic Fibrosis. Am. J. Respir. Crit. Care Med. 178: 814-821 [Abstract] [Full Text]  
  • Bosch, A., Minan, A., Vescina, C., Degrossi, J., Gatti, B., Montanaro, P., Messina, M., Franco, M., Vay, C., Schmitt, J., Naumann, D., Yantorno, O. (2008). Fourier Transform Infrared Spectroscopy for Rapid Identification of Nonfermenting Gram-Negative Bacteria Isolated from Sputum Samples from Cystic Fibrosis Patients. J. Clin. Microbiol. 46: 2535-2546 [Abstract] [Full Text]  
  • Vergison, A., Denis, O., Deplano, A., Casimir, G., Claeys, G., DeBaets, F., DeBoeck, K., Douat, N., Franckx, H., Gigi, J., Ieven, M., Knoop, C., Lebeque, P., Lebrun, F., Malfroot, A., Paucquay, F., Pierard, D., Van Eldere, J., Struelens, M. J. (2007). National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients. J Antimicrob Chemother 59: 893-899 [Abstract] [Full Text]